文献速递脑血管病

微栓子信号在成人烟雾病缺血性卒中中的临床作用

Clinical Role of Microembolic Signals in Adult Moyamoya Disease With Ischemic Stroke.
PubMed 文献 · Stroke · 2019-01-01

研究纳入48例新诊断成人烟雾病(MMD)患者,经颅多普勒监测大脑中动脉微栓子信号(MES)。23%患者检出MES,MES与近期缺血事件(P=0.024)及高平均血流速度(P=0.016)相关,多见于Suzuki I-II期。校正后两者均为MES独立预测因素。

要点

  • 成人MMD患者中MES检出率23%,与近期缺血事件独立相关。
  • MES多见于高平均血流速度及早期(Suzuki I-II期)MMD。
  • 抗血小板治疗对MES阳性MMD的疗效尚需随机对照研究验证。

核心结论

  • MES见于高平均血流速度患者,尤其是早期MMD,且与近期缺血事件临床相关。
  • 抗血小板药物治疗MES阳性MMD的疗效需随机对照研究确定。

研究设计与样本

  • 研究纳入48例年龄20-60岁新诊断MMD患者,按Suzuki分期进行血管造影分类。
  • 双侧大脑中动脉行经颅多普勒监测30分钟检测MES,并评估平均血流速度。

主要发现

  • 48例中11例(23%)检出MES,89个检查半球中11个(12%)检出,平均MES数量2个(范围1-6)。
  • 11个检出MES半球中6个(55%)表现为缺血性卒中或TIA,2个(18%)表现为出血性卒中。
  • MES存在与近期缺血事件(P=0.024)和高平均血流速度(P=0.016)相关,常见于Suzuki I和II期。
  • 校正年龄、性别和抗血小板药物后,近期缺血事件(OR 6.294;95%CI 1.345-29.457;P=0.019)和高平均血流速度(OR 6.172;95%CI 1.235-31.25;P=0.027)为MES独立预测因素。

关键数值与推荐

  • 平均血流速度分类:低<40 cm/s,正常40-80 cm/s,高>80 cm/s。
  • MES检出与近期缺血事件相关(P=0.024),校正后OR 6.294(95%CI 1.345-29.457;P=0.019)。
  • MES检出与高平均血流速度相关(P=0.016),校正后OR 6.172(95%CI 1.235-31.25;P=0.027)。

临床怎么用

  • 对成人MMD患者,尤其高血流速度及早期Suzuki分期者,可考虑经颅多普勒监测MES以评估缺血风险。
  • MES阳性提示近期缺血事件风险增高,但抗血小板治疗决策需个体化并等待随机对照研究证据。

局限性

  • 研究为观察性设计,样本量48例,MES检出半球数较少。
  • 抗血小板药物对MES阳性MMD的疗效尚未经随机对照研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Hemodynamic compromise has been implicated in moyamoya disease (MMD) with transient ischemic attacks or ischemic stroke. However, increasing evidence supports the notion that artery-to-artery embolism may also contribute to ischemic events based on microembolic signal (MES) monitoring. Methods- A total of 48 patients aged between 20 and 60 years with newly diagnosed MMD were enrolled and angiographically classified according to the Suzuki staging system. For detection of MESs, transcranial Doppler was performed at the middle cerebral artery bilaterally for a 30-minute period. Mean flow velocities in the middle cerebral artery were also evaluated and categorized into low (<40 cm/s), normal (40-80 cm/s), and high (>80 cm/s). Clinical characteristics, cerebral angiography findings, recent ischemic events within 3 months, and antiplatelet medication were correlated with transcranial Doppler findings. Results- MESs were detected in 11 of the 48 patients (23%), with a frequency of 11 of 89 (12%) examined hemispheres. The mean number of MESs was 2 (range, 1-6). Six of the 11 hemispheres (55%) presented with ischemic strokes or transient ischemic attacks, and 2 (18%) presented with hemorrhagic strokes. The presence of MESs was associated with recent ischemic events ( P=0.024) and high mean flow velocities ( P=0.016), which was usually observed in Suzuki stage I and II (early-stage MMD). After controlling for age, sex, and antiplatelet medication, both recent ischemic events (odds ratio, 6.294; 95% CI, 1.345-29.457; P=0.019) and high mean flow velocities (odds ratio, 6.172; 95% CI, 1.235-31.25; P=0.027) were found to be independent predictors of MESs. Conclusions- MESs were observed in patients with high mean flow velocities, particularly early-stage MMD, and clinically associated with recent ischemic events. A randomized controlled study is necessary to determine the efficacy of antiplatelet agents in the treatment of MES-positive MMD.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jeon C, Yeon JY, Jo KI, et al. Clinical Role of Microembolic Signals in Adult Moyamoya Disease With Ischemic Stroke. Stroke. 2019. PMID: 30935317. doi:10.1161/STROKEAHA.118.022490

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。